We are live on ! Find out more
GA

Geneva Advisors Portfolio holdings

AUM $5.81B
1-Year Est. Return 23.71%
This Fund
S&P 500
This Quarter Est. Return
+5.3%
1 Year Est. Return
+23.71%
3 Year Est. Return
+53.12%
5 Year Est. Return
10 Year Est. Return
AUM
$5.53B
AUM Growth
+$159M
Cap. Flow
-$12.4M
Cap. Flow %
-0.22%
Top 10 Hldgs %
20.92%
Holding
797
New
64
Increased
251
Reduced
262
Closed
82

Top Sells

Rank Stock Value
1
JNJ icon
Johnson & Johnson
JNJ
+$55.7M
2
ITC
ITC HOLDINGS CORP
ITC
+$38.9M
3
AGN
Allergan Inc
AGN
+$38.3M
4
ACN icon
Accenture
ACN
+$37.2M
5
TSLA icon
Tesla
TSLA
+$35.7M

Sector Composition

Rank Sector Weight
1 Healthcare 19.43%
2 Financials 16.55%
3 Consumer Discretionary 12.19%
4 Industrials 12.01%
5 Technology 10.81%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
ESRX
176
DELISTED
Express Scripts Holding Company
ESRX
$2.68M 0.05%
30,871
-23
-0.1% -$1.93K
ORCL icon
177
Oracle
ORCL
$438B
$2.67M 0.05%
61,945
-5,068
-8% -$220K
VZ icon
178
Verizon
VZ
$205B
$2.67M 0.05%
54,827
-2,015
-4% -$97.3K
EMC
179
DELISTED
EMC CORPORATION
EMC
$2.57M 0.05%
100,690
-12,559
-11% -$346K
GIS icon
180
General Mills
GIS
$21.6B
$2.55M 0.05%
45,114
-4,712
-9% -$251K
CAT icon
181
Caterpillar
CAT
$376B
$2.53M 0.05%
31,660
-741
-2% -$61.6K
MRSH
182
Marsh
MRSH
$90.7B
$2.52M 0.05%
44,840
MO icon
183
Altria Group
MO
$113B
$2.49M 0.05%
49,822
+241
+0.5% +$12.8K
LOPE icon
184
Grand Canyon Education
LOPE
$3.91B
$2.49M 0.05%
57,527
-17,689
-24% -$793K
NVS icon
185
Novartis
NVS
$294B
$2.49M 0.05%
28,152
-4,143
-13% -$367K
ORLY icon
186
O'Reilly Automotive
ORLY
$71.1B
$2.45M 0.04%
169,950
COP icon
187
ConocoPhillips
COP
$156B
$2.41M 0.04%
38,759
-2,884
-7% -$186K
MDY icon
188
State Street SPDR S&P MIDCAP 400 ETF Trust
MDY
$26.7B
$2.33M 0.04%
8,408
+200
+2% +$53.9K
CHSCO
189
CHS Inc Class B Preferred Stock
CHSCO
$559M
$2.29M 0.04%
80,105
-500
-0.6% -$14.2K
NLY.PRD
190
DELISTED
Annaly Capital Management, Inc. 7.50% Series D Cumulative Redeemable Preferred Stock
NLY.PRD
$2.26M 0.04%
89,795
+2,800
+3% +$70.6K
CSCO icon
191
Cisco
CSCO
$442B
$2.24M 0.04%
81,308
-2,585
-3% -$72.8K
CRTO icon
192
Criteo S.A.
CRTO
$845M
$2.23M 0.04%
+56,539
New +$2.35M
IVV icon
193
iShares Core S&P 500 ETF
IVV
$900B
$2.21M 0.04%
10,655
+508
+5% +$106K
URI icon
194
United Rentals
URI
$64.6B
$2.19M 0.04%
24,079
-147,205
-86% -$13.2M
CNI icon
195
Canadian National Railway
CNI
$76.5B
$2.19M 0.04%
32,761
-60,752
-65% -$4.13M
MNST icon
196
Monster Beverage
MNST
$91.5B
$2.16M 0.04%
187,080
+34,380
+23% +$360K
AL
197
DELISTED
Air Lease Corp
AL
$2.14M 0.04%
56,730
-150
-0.3% -$5.51K
NJ
198
DELISTED
NIDEC CP (NIHON KABUSHIKI KAISHA)1 ADS REPTG .25 SH COM STK
NJ
$2.11M 0.04%
+126,280
New +$2.12M
EMBJ
199
Embraer S.A. ADS
EMBJ
$13.4B
$2.11M 0.04%
68,496
-37,371
-35% -$1.27M
MOS icon
200
The Mosaic Company
MOS
$7.55B
$2.05M 0.04%
44,578
-388
-0.9% -$18.9K

Similar funds

Geneva Advisors's Q1 2015 Portfolio in Review

As of Q1 2015, Geneva Advisors held 797 positions worth $5.53B, up 3% from $5.37B the previous quarter. Its ten largest holdings account for 21% of the portfolio.

Geneva Advisors's Q1 2015 filing shows 64 new, 251 increased, 262 reduced and 82 closed positions. Its largest new stake was Ulta Beauty: 303,437 shares worth $45.8M. The largest sale was Johnson & Johnson, an estimated $55.7M.

By sector, the portfolio is most concentrated in Healthcare at 19% of assets, up from 19% a quarter earlier, followed by Financials and Consumer Discretionary.

  • Geneva Advisors's largest Q1 2015 buy was Ulta Beauty: 303,437 shares worth $45.8M.
  • Geneva Advisors added most to CF Industries in Q1 2015, an estimated $41.4M increase.
  • Geneva Advisors's biggest Q1 2015 reduction was Johnson & Johnson, cutting an estimated $55.7M.
  • Geneva Advisors fully exited Allergan Inc in Q1 2015, selling an estimated $38.3M.
  • Geneva Advisors's ten largest holdings make up 21% of its $5.53B portfolio in Q1 2015.
  • Geneva Advisors opened 64 new positions and closed 82 in Q1 2015.
  • Geneva Advisors's portfolio value rose 3% quarter-over-quarter to $5.53B.

Based on Geneva Advisors's 13F filing for Q1 2015, filed 5 May 2015.